Return On Equity in % of PDS Biotechnology Corp from Q2 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
PDS Biotechnology Corp quarterly and annual Return On Equity history and change rate from Q2 2016 to Q3 2025.
  • PDS Biotechnology Corp Return On Equity for the quarter ending 30 Sep 2025 was -209%, a 50% decline year-over-year.
  • PDS Biotechnology Corp annual Return On Equity for 2024 was -138%, a 0.4% increase from 2023.
  • PDS Biotechnology Corp annual Return On Equity for 2023 was -138%, a 68% decline from 2022.
  • PDS Biotechnology Corp annual Return On Equity for 2022 was -82%, a 178% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

PDS Biotechnology Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -209% -69% -50% 01 Jul 2025 30 Sep 2025
Q2 2025 -185% -48% -35% 01 Apr 2025 30 Jun 2025
Q1 2025 -151% -4.6% -3.2% 01 Jan 2025 31 Mar 2025
Q4 2024 -138% +0.56% +0.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -140% +4.7% +3.2% 01 Jul 2024 30 Sep 2024
Q2 2024 -137% -21% -18% 01 Apr 2024 30 Jun 2024
Q1 2024 -146% -54% -59% 01 Jan 2024 31 Mar 2024
Q4 2023 -138% -56% -68% 01 Oct 2023 31 Dec 2023
Q3 2023 -144% -93% -180% 01 Jul 2023 30 Sep 2023
Q2 2023 -116% -70% -151% 01 Apr 2023 30 Jun 2023
Q1 2023 -92% -57% -167% 01 Jan 2023 31 Mar 2023
Q4 2022 -82% -53% -178% 01 Oct 2022 31 Dec 2022
Q3 2022 -52% -21% -69% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% -17% -55% 01 Apr 2022 30 Jun 2022
Q1 2022 -34% +22% +38% 01 Jan 2022 31 Mar 2022
Q4 2021 -30% +33% +53% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% +45% +60% 01 Jul 2021 30 Sep 2021
Q2 2021 -30% +75% +72% 01 Apr 2021 30 Jun 2021
Q1 2021 -56% +49% +47% 01 Jan 2021 31 Mar 2021
Q4 2020 -62% -24% -61% 01 Oct 2020 31 Dec 2020
Q3 2020 -75% -44% -138% 01 Jul 2020 30 Sep 2020
Q2 2020 -105% -109% -2849% 01 Apr 2020 30 Jun 2020
Q1 2020 -105% -178% -245% 01 Jan 2020 31 Mar 2020
Q4 2019 -39% -401% -111% 01 Oct 2019 31 Dec 2019
Q3 2019 -32% -2322% -101% 01 Jul 2019 30 Sep 2019
Q2 2019 3.8% +149% 01 Apr 2019 30 Jun 2019
Q1 2019 73% +172% 01 Jan 2019 31 Mar 2019
Q4 2018 362% +448% 01 Oct 2018 31 Dec 2018
Q3 2018 2291% +2348% 01 Jul 2018 30 Sep 2018
Q2 2018 -145% -93% -176% 01 Apr 2018 30 Jun 2018
Q1 2018 -100% -55% -122% 01 Jan 2018 31 Mar 2018
Q4 2017 -86% -48% -126% 01 Oct 2017 31 Dec 2017
Q3 2017 -57% -23% -68% 01 Jul 2017 30 Sep 2017
Q2 2017 -53% -2.6% -5.2% 01 Apr 2017 30 Jun 2017
Q1 2017 -45% 01 Jan 2017 31 Mar 2017
Q4 2016 -38% 01 Oct 2016 31 Dec 2016
Q3 2016 -34% 01 Jul 2016 30 Sep 2016
Q2 2016 -50% 01 Apr 2016 30 Jun 2016

PDS Biotechnology Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -138% +0.56% +0.4% 01 Jan 2024 31 Dec 2024
2023 -138% -56% -68% 01 Jan 2023 31 Dec 2023
2022 -82% -53% -178% 01 Jan 2022 31 Dec 2022
2021 -30% +33% +53% 01 Jan 2021 31 Dec 2021
2020 -62% -24% -61% 01 Jan 2020 31 Dec 2020
2019 -39% -401% -111% 01 Jan 2019 31 Dec 2019
2018 362% +448% 01 Jan 2018 31 Dec 2018
2017 -86% -48% -126% 01 Jan 2017 31 Dec 2017
2016 -38% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.